Evidence map›Paper›PMID 37142423›Full record

ArticleTobacco control2024

Health, economic and social burden of tobacco in Latin America and the expected gains of fully implementing taxes, plain packaging, advertising bans and smoke-free environments control measures: a modelling study.

Andrés Pichon-Riviere, Ariel Bardach, Federico Rodríguez Cairoli, Agustín Casarini, Natalia Espinola, Lucas Perelli, Luz Myriam Reynales-Shigematsu, Blanca Llorente, Marcia Pinto, Belén Saenz De Miera Juárez and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Tobacco control, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. The role of regulatory policies on unhealthy commodities to prevent and control noncommunicable diseases in the Americas.Revista panamericana de salud publica = Pan American journal of public health · 2026
    Article
  3. Article
  4. Article
  5. The triple cost of tobacco and sugary drinks: health, economy and the environment.Revista peruana de medicina experimental y salud publica · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Cardiovascular Statistics - Brazil 2023.Arquivos brasileiros de cardiologia · 2024
    Article
  11. Article
  12. Article
  13. What does Google Trends reveal about the proportion of waterpipe users in the Brazilian population?Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil · 2023
    Article
  14. Tobacco control in latin america: achievements, gaps and new challenges.Revista peruana de medicina experimental y salud publica · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 8 countries.

Andrés Pichon-RiviereDepartment of Health Technology Assessment and Health Economics, IECS-Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina apichon@iecs.org.ar.ORCID 0000-0001-6052-025X
Ariel BardachDepartment of Health Technology Assessment and Health Economics, IECS-Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Federico Rodríguez CairoliDepartment of Health Technology Assessment and Health Economics, IECS-Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Agustín CasariniDepartment of Health Technology Assessment and Health Economics, IECS-Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Natalia EspinolaDepartment of Health Technology Assessment and Health Economics, IECS-Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Lucas PerelliDepartment of Health Technology Assessment and Health Economics, IECS-Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Luz Myriam Reynales-ShigematsuDepartamento de Investigación sobre Tabaco, Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.ORCID 0000-0002-5350-0928
Blanca LlorenteResearch Department, Fundación Anáas, Bogota, Colombia.
Marcia PintoInstituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Belén Saenz De Miera JuárezDepartment of Economics, Autonomous University of Baja California Sur, La Paz, Baja California Sur, Mexico.
Tatiana VillacresHealth Economics, Pontificia Universidad Católica del Ecuador, Quito, Pichincha, Ecuador.
Esperanza Peña TorresFaculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.
Nydia AmadorCosta Rica Saludable, San José, Costa Rica.
César LozaFaculty of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.
Marianela Castillo-RiquelmeFaculty of Medicine, Universidad de Chile Escuela de Salud Publica, Santiago, Chile.
Javier RobertiCIESP, CONICET, Buenos Aires, Argentina.ORCID 0000-0002-4285-5061
Federico AugustovskiDepartment of Health Technology Assessment and Health Economics, IECS-Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Andrea AlcarazDepartment of Health Technology Assessment and Health Economics, IECS-Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Alfredo PalaciosDepartment of Health Technology Assessment and Health Economics, IECS-Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.ORCID 0000-0001-7684-0880
Instituto de Efectividad Clínica y Sanitaria · ARConsejo Nacional de Investigaciones Científicas y Técnicas · ARFundação Oswaldo Cruz · BRFundación Universitaria Sanitas · COInstituto de Salud Pública de Chile · CLInstituto Nacional de Salud Pública · MXMinisterio de Agricultura y Ganadería de Costa Rica · CRPontificia Universidad Católica del Ecuador · ECPontificia Universidad Javeriana · COUniversidad Autónoma de Baja California · MXUniversidad Peruana Cayetano Heredia · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the tobacco-attributable burden on disease, medical costs, productivity losses and informal caregiving; and to estimate the health and economic gains that can be achieved if the main tobacco control measures (raising taxes on tobacco, plain packaging, advertising bans and smoke-free environments) are fully implemented in eight countries that encompass 80% of the Latin American population.

designMarkov probabilistic microsimulation economic model of the natural history, costs and quality of life associated with the main tobacco-related diseases. Model inputs and data on labour productivity, informal caregivers' burden and interventions' effectiveness were obtained through literature review, surveys, civil registrations, vital statistics and hospital databases. Epidemiological and economic data from January to October 2020 were used to populate the model.

findingsIn these eight countries, smoking is responsible each year for 351 000 deaths, 2.25 million disease events, 12.2 million healthy years of life lost, US$22.8 billion in direct medical costs, US$16.2 billion in lost productivity and US$10.8 billion in caregiver costs. These economic losses represent 1.4% of countries' aggregated gross domestic products. The full implementation and enforcement of the four strategies: taxes, plain packaging, advertising bans and smoke-free environments would avert 271 000, 78 000, 71 000 and 39 000 deaths, respectively, in the next 10 years, and result in US$63.8, US$12.3, US$11.4 and US$5.7 billions in economic gains, respectively, on top of the benefits being achieved today by the current level of implementation of these measures.

conclusionsSmoking represents a substantial burden in Latin America. The full implementation of tobacco control measures could successfully avert deaths and disability, reduce healthcare spending and caregiver and productivity losses, likely resulting in large net economic benefits.

Indexed as

AdvertisingCost of IllnessModels, EconomicProduct PackagingTaxesHealth Care CostsHumansLatin AmericaMarkov ChainsQuality of LifeSmoke-Free PolicySmokingSmoking PreventionTobacco ProductsTobacco Smoke PollutionTobacco Smoke PollutionAdvertising and PromotionLow/Middle income countryPackaging and LabellingPublic policyTaxation

Identifiers

PMID37142423
PMCPMC11503199
OpenAlexW4368373963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.